Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;65(3):398-400.
doi: 10.1136/ard.2005.040998. Epub 2005 Aug 11.

Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation

G M Alenius  1 , E Berglin, S Rantapää Dahlqvist
Affiliations

Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation

G M Alenius et al. Ann Rheum Dis. 2006 Mar.

Abstract

Objective: To compare the prevalence of anti-CCP antibodies in psoriatic patients with and without joint inflammation, patients with early RA, and controls.

Methods: Anti-CCP antibodies (cut off level 5 U/ml) were measured in 160 patients with psoriatic arthritis (PsA), 146 patients with psoriasis but no arthritic disease, 101 patients with early RA, and 102 healthy controls by ELISA.

Results: 11 (7%) patients with PsA, 75 (74%) patients with early RA, 2 (2%) healthy controls (2%), and 1 (0.7%) patient with psoriasis without arthritis had anti-CCP antibodies above the cut off level. The presence of anti-CCP antibodies was not related to radiological changes and/or deformity and functional impairment in PsA. 8/11 patients with PsA and anti-CCP antibodies had a polyarthritic disease, and all fulfilled the ACR criteria for RA at 4 year follow up. Five of these 8 patients also had manifestations such as dactylitis, DIP involvement, radiological changes associated with PsA, and/or enthesitis. In multiple logistic regression analysis with polyarthritis as the dependent variable, anti-CCP antibodies and rheumatoid factor significantly distinguished RA from PsA.

Conclusions: Anti-CCP antibodies were more prevalent in patients with PsA than in patients with psoriasis without arthritis, but less prevalent than in patients with early RA. Patients with PsA positive for anti-CCP antibodies more often had polyarthritic disease, but the presence of anti-CCP antibodies did not relate to radiological changes and/or deformity and functional impairment.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Moll J M H, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973355–78. - PubMed
    1. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A.et al The European Spondylarthropathy Study Group: the European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991341218–1227. - PubMed
    1. Helliwell P S, Taylor W J. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 200564(Suppl II)ii3–ii8. - PMC - PubMed
    1. Rantapää Dahlqvist S. Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol 20053483–96. - PubMed
    1. Schellekens G A, Visser H, de Jong B A, van den Hoogen F H, Hazes J M, Breedveld F C.et al The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 200043155–163. - PubMed

Publication types